The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

Egger, 1997, Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study., BMJ, 315, 1194, 10.1136/bmj.315.7117.1194

Detels, 1998, Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators., JAMA, 280, 1497, 10.1001/jama.280.17.1497

Wada, 2013, Cause-specific life expectancies after age 35 for HIV-infected and HIV-negative individuals followed simultaneously in long-term cohort studies: 1984-2008., Am J Epidemiol, 177, 116, 10.1093/aje/kws321

Lederman, 2013, Residual immune dysregulation syndrome in treated HIV infection., Adv Immunol, 119, 51, 10.1016/B978-0-12-407707-2.00002-3

Plaeger, 2012, Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary., AIDS Res Hum Retroviruses, 28, 469, 10.1089/aid.2011.0213

Hunt, 2003, T cell activation is associated with lower CD4 T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy., J Infect Dis, 187, 1534, 10.1086/374786

Lederman, 2011, Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells., J Infect Dis, 204, 1217, 10.1093/infdis/jir507

Hazenberg, 2003, Persistent immune activation in HIV-1 infection is associated with progression to AIDS., AIDS, 17, 1881, 10.1097/00002030-200309050-00006

Brenchley, 2006, Microbial translocation is a cause of systemic immune activation in chronic HIV infection., Nat Med, 12, 1365, 10.1038/nm1511

Hatano, 2013, Immune activation and HIV persistence: considerations for novel therapeutic interventions., Curr Opin HIV AIDS, 8, 211, 10.1097/COH.0b013e32835f9788

Regidor, 2011, Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation., AIDS, 25, 303, 10.1097/QAD.0b013e32834273ad

Widney, 2005, Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection., J Interferon Cytokine Res, 25, 702, 10.1089/jir.2005.25.702

Kaplan, 2012, Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment., J Acquir Immune Deficiency Syndr, 60, 359, 10.1097/QAI.0b013e31825b03be

Neuhaus, 2010, Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection., J Infect Dis, 201, 1788, 10.1086/652749

Kaslow, 1987, The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants., Am J Epidemiol, 126, 310, 10.1093/aje/126.2.310

Hultin, 2007, Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods., Cytometry B Clin Cytom, 72, 249, 10.1002/cyto.b.20176

Schneider, 2012, Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy., J Acquir Immune Defic Syndr, 59, 389, 10.1097/QAI.0b013e318246bfce

Cox, 2007, Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution., Stat Med, 26, 4352, 10.1002/sim.2836

Dunn, 1961, Multiple comparisons among means., J Am Stat Assoc, 50, 1096

Bosch, 2013, Study design issues in evaluating immune biomarkers., Curr Opin HIV AIDS, 8, 147, 10.1097/COH.0b013e32835d3259

Crotty, 2011, Follicular helper CD4 T cells (TFH)., Ann Rev Immunol, 29, 621, 10.1146/annurev-immunol-031210-101400

Kumar, 2013, TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy., Mediators Inflamm, 2013, 484378, 10.1155/2013/484378

Sandler, 2011, Plasma levels of soluble CD14 independently predict mortality in HIV infection., J Infect Dis, 203, 780, 10.1093/infdis/jiq118

Cassol, 2009, M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms., J Immunol, 182, 6237, 10.4049/jimmunol.0803447

Herbein, 2010, The macrophage in HIV-1 infection: from activation to deactivation., Retrovirology, 7, 33, 10.1186/1742-4690-7-33

Zhang, 2013, Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis., J Nephrol, 26, 243, 10.5301/jn.5000169

Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men., N Engl J Med, 336, 973, 10.1056/NEJM199704033361401

Swede, 2014, Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort., Int J Cancer, 134, 1862, 10.1002/ijc.28504

Klatt, 2013, Immune activation and HIV persistence: implications for curative approaches to HIV infection., Immunol Rev, 254, 326, 10.1111/imr.12065

Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing., J Royal Stat Soc Series B, 57, 289

Kamat, 2012, A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy., PLoS One, 7, e30881, 10.1371/journal.pone.0030881